Modifications of glycans: biological significance and therapeutic opportunities
about
Polysaccharide nanosystems for future progress in cardiovascular pathologiesGlycotherapy: new advances inspire a reemergence of glycans in medicineComplement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epitheliumMammalian protein glycosylation--structure versus function.Glycan Reader is Improved to Recognize Most Sugar Types and Chemical Modifications in the Protein Data Bank.Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment.Sugar-modified foldamers as conformationally defined and biologically distinct glycopeptide mimicsGlycosyltransferases: carb loading strategy is spot on.Metabolic fate of neutral human milk oligosaccharides in exclusively breast-fed infants.Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource DatabaseThe third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.Shaping up for structural glycomics: a predictive protocol for oligosaccharide conformational analysis applied to N-linked glycans.Novel spatiotemporal glycome changes in the murine placenta during placentation based on BS-I lectin binding patterns.Simple sugars to complex disease--mucin-type O-glycans in cancer.Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.Anharmonic simulations of the vibrational spectrum of sulfated compounds: application to the glycosaminoglycan fragment glucosamine 6-sulfate.Carbene-mediated functionalization of the anomeric C-H bond of carbohydrates: scope and limitations.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies.Activation energies of fragmentations of disaccharides by tandem mass spectrometry.Differentiation of isomeric β-(1-4) hexose disaccharides by positive electrospray tandem mass spectrometry
P2860
Q27025494-35B35AA1-5E58-4EC2-BBD6-3ECF9FCA8B50Q27027997-0F49D1F4-D203-457A-AD93-9375F906CD32Q28542387-D2FA3EA5-4CE2-4165-9CFE-81B1C00A0A9DQ33358345-56263F1D-C8FD-42C3-96AF-A6606FDFF3C6Q33459363-18030675-C59F-4FEB-81D6-1CA7B0E42F8BQ33676699-F384E577-6141-4085-A2FF-13D2741B8D46Q34205779-BF290AAE-410C-4032-970A-FB79B9ED3845Q34385951-7665975E-B4BA-4AE5-95DC-22135938254AQ35350052-7E120383-8010-45BF-8AC3-F29CE4233289Q37105366-1077A61A-F1FB-4B92-BC8F-C333983EF660Q38096239-FBC9A1A5-1C8C-4524-86C9-B48C28559DDFQ38221786-906B7CD4-D524-4E10-B0CF-9C1308876783Q38311087-7AB3CAEA-DF86-4161-8C73-2AF57FE669BAQ38316410-EF97C5DD-0025-4651-83B8-B31500B08AAAQ38366325-051AFB70-92B2-4373-9777-AAF836C326F9Q38883962-2BD136FA-2900-48A5-8B73-4F796A0B7B7DQ40789136-7428001D-AA08-430A-A930-CD1E142207B9Q45712826-9F1447C3-D70B-4AE5-9C32-747951E17435Q47281580-663B870C-8D5C-411E-AD0F-5C94E63118B6Q50199955-3753DAAE-631B-4748-BB55-DBCA668DA812Q51123835-FE1F8404-DB56-44B8-8A8A-8A3757C89D82Q58877914-08DD0211-C007-4ED6-82D2-BE1A548B1CD4
P2860
Modifications of glycans: biological significance and therapeutic opportunities
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Modifications of glycans: biological significance and therapeutic opportunities
@ast
Modifications of glycans: biological significance and therapeutic opportunities
@en
Modifications of glycans: biological significance and therapeutic opportunities
@nl
type
label
Modifications of glycans: biological significance and therapeutic opportunities
@ast
Modifications of glycans: biological significance and therapeutic opportunities
@en
Modifications of glycans: biological significance and therapeutic opportunities
@nl
prefLabel
Modifications of glycans: biological significance and therapeutic opportunities
@ast
Modifications of glycans: biological significance and therapeutic opportunities
@en
Modifications of glycans: biological significance and therapeutic opportunities
@nl
P2093
P2860
P356
P1433
P1476
Modifications of glycans: biological significance and therapeutic opportunities
@en
P2093
Christopher T Campbell
Jeffrey C Gildersleeve
Saddam M Muthana
P2860
P356
10.1021/CB2004466
P577
2012-01-11T00:00:00Z